Cyntellect is a company established in 1998 with a focus on creating new benchmarks in cell analysis, purification, and processing technology. Their products cater to various applications such as advancing life science research, biopharmaceutical production, stem cell research, and drug discovery. The company's technology utilizes in situ, microplate-based cytometry to analyze cells with minimal sample manipulation and process cells with precision and efficiency.
The last investment in Cyntellect was a $9.00M Series E investment on 16 July 2010. This funding is anticipated to support the company’s expanding cellular analysis and processing portfolio, allowing it to have a significant role in the future of advanced cell-based diagnostics and therapeutics.
The company operates in the Analytics, Biotechnology, and Health Care industries. More information about Cyntellect can be found at their website www.cyntellect.com.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series E | $9.00M | - | 16 Jul 2010 | |
| Venture Round | $15.50M | - | 12 Nov 2009 | |
| Series D | $3.00M | 2 |
|
06 Sep 2007 |
| Series D | $15.10M | 1 | Third Security | 25 Jul 2007 |
| Series C | Unknown | - | 27 Apr 2005 |
No recent news or press coverage available for Cyntellect.
We care about your data, and we'd love to use cookies make your experience better.